TERT and breast cancer: Interestingly, all six samples of primary invasive CSCC and lymph node metastases from three different patients, including one sample from the patient who developed CSCC between two BC events, demonstrated similar TERT gene promotor mutations as seen in BC, but lacked HRAS gene alterations.